Table 5.
Clinical outcomes by treatment group.
IMN | ORIF | P | Adjusted P | |
Time to WBAT, wk, mean (SD) | 10.3 (3.1) | 10.3 (2.0) | 0.985 | 0.798 |
Time to ROM (>90), wk, mean (SD) | 13.7 (10.3) | 10.2 (6.3) | 0.195 | 0.526 |
Patients with less than 6 months of follow-up time were excluded from these analyses. The number of valid time to WBAT values was 21 IMN patients and 23 ORIF patients. The number of valid time to ROM values was 21 IMN patients and 21 ORIF patients. Patients without valid outcomes either did not reach the end point by the end of the study or did not have an outcome value that could be located in patient records. Adjusted P-values represent P-values for the treatment group (IMN vs. ORIF) parameter estimate from a multiple linear regression model for the corresponding outcome variable, controlling for patient sex, age, BMI, comorbidities (smoking, diabetes, osteoarthritis), initial joint line displacement, and initial condylar widening.